Literature DB >> 3960691

Pharmacokinetics: metabolism and renal excretion of quinolones in man.

T B Vree, W J Wijnands, P J Guelen, A M Baars, Y A Hekster.   

Abstract

The quinolones are relatively poorly absorbed from the gastrointestinal tract. The elimination proceeds mainly by renal excretion. The half-life of elimination depends on the molecular structure and varies between 2 and 10 h. Impaired kidney function is expected to increase the half-life of elimination, though this effect is not always observed. Since the 4-oxo-metabolites show a higher renal clearance than the parent drug, renal impairment will result in a cumulation of the metabolites in the body.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3960691     DOI: 10.1007/bf01975476

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  41 in total

1.  High-performance liquid chromatographic method for determination of ciprofloxacin in biological fluids.

Authors:  F Jehl; C Gallion; J Debs; J M Brogard; H Monteil; R Minck
Journal:  J Chromatogr       Date:  1985-05-03

2.  The pharmacokinetics and tissue penetration of norfloxacin.

Authors:  Z N Adhami; R Wise; D Weston; B Crump
Journal:  J Antimicrob Chemother       Date:  1984-01       Impact factor: 5.790

3.  Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.

Authors:  J Shimada; T Yamaji; Y Ueda; H Uchida; H Kusajima; T Irikura
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

4.  The clinical pharmacokinetics and tolerance of enoxacin in healthy volunteers.

Authors:  R Wolf; R Eberl; A Dunky; N Mertz; T Chang; J R Goulet; J Latts
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

5.  Determination of a new antibacterial agent (AT-2266) and its metabolites in plasma and urine by high-performance liquid chromatography.

Authors:  R Nakamura; T Yamaguchi; Y Sekine; M Hashimoto
Journal:  J Chromatogr       Date:  1983-12-09

6.  Pharmacokinetics of norfloxacin (MK 366) in patients with impaired kidney function--some preliminary results.

Authors:  P J Hughes; D B Webb; A W Asscher
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

7.  Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers.

Authors:  W Wingender; K H Graefe; W Gau; D Förster; D Beermann; P Schacht
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

8.  Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.

Authors:  B Ledergerber; J D Bettex; B Joos; M Flepp; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

9.  Pharmacokinetics and tissue penetration of enoxacin.

Authors:  R Wise; R Lockley; J Dent; M Webberly
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

10.  Nalidixic acid kinetics after single and repeated oral doses.

Authors:  N Ferry; G Cuisinaud; N Pozet; P Y Zech; J Sassard
Journal:  Clin Pharmacol Ther       Date:  1981-05       Impact factor: 6.875

View more
  7 in total

Review 1.  Saturable pharmacokinetics in the renal excretion of drugs.

Authors:  C A van Ginneken; F G Russel
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

Review 2.  Pharmacokinetics of the newer fluoroquinolones.

Authors:  J R Brouwers
Journal:  Pharm Weekbl Sci       Date:  1987-12-11

3.  Distribution kinetics of enoxacin and its metabolite oxoenoxacin in excretory fluids of healthy volunteers.

Authors:  U Jaehde; F Sörgel; K G Naber; J Zürcher; W Schunack
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 4.  Pharmacokinetics of ciprofloxacin.

Authors:  T Bergan; A Dalhoff; R Rohwedder
Journal:  Infection       Date:  1988       Impact factor: 3.553

5.  Pharmacokinetics of intravenously administered ciprofloxacin in intensive care patients with acute renal failure.

Authors:  M S Dirksen; T B Vree
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

6.  Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.

Authors:  W J Wijnands; T B Vree; A M Baars; C L van Herwaarden
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Pharmacokinetics of nalidixic acid in man: hydroxylation and glucuronidation.

Authors:  T B Vree; W J Wijnands; A M Baars; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1988-10-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.